Cargando…
Nonsteroidal Anti-Inflammatory Drugs, Gastroprotection, and Benefit–Risk
BACKGROUND: Gastroprotective agents (GPA) substantially reduce morbidity and mortality with long-term nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin. OBJECTIVE: To evaluate efficacy of NSAIDs, protection against NSAID-induced gastrointestinal harm, and balance of benefit and risk. METHODS...
Autores principales: | Moore, Robert Andrew, Derry, Sheena, Simon, Lee S, Emery, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238833/ https://www.ncbi.nlm.nih.gov/pubmed/23941628 http://dx.doi.org/10.1111/papr.12100 |
Ejemplares similares
-
Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk
por: Moore, R Andrew, et al.
Publicado: (2007) -
Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital
por: Lee, Hooi Leng, et al.
Publicado: (2016) -
Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
por: Moore, R Andrew, et al.
Publicado: (2006) -
Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits
por: Gwee, Kok Ann, et al.
Publicado: (2018) -
Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes
por: Moore, R Andrew, et al.
Publicado: (2008)